UPDATE: Nonclinical Reproductive Toxicity Information in Assessing Human Risk Joseph J. DeGeorge Ph.D. Associate Director for Pharmacology and Toxicology Office of Review Management CDER, FDA

5/12/00


Click here to start


Table of Contents

UPDATE: Nonclinical Reproductive Toxicity Information in Assessing Human Risk Joseph J. DeGeorge Ph.D. Associate Director for Pharmacology and Toxicology Office of Review Management CDER, FDA

Defining the Issue

PPT Slide

Integration Working Group

PPT Slide

Objectives Of Integration Working Group

Approach Taken

Product

Integrated Analysis of Positive Signals

Presentations

General Feedback

Current Status

Reproductive Toxicology Committee

PPT Slide

PPT Slide

Current Status

Author: Joe DeGeorge